** Index of Australian Healthcare stocks .AXHJ rises 1.9%, tracking broadly positive market sentiment .AX
** Bell Potter says that most healthcare firms remain unaffected from tariff impacts, but Nanosonics NAN.AX, Aroa ARX.AX, and Trajan TRJ.AX, which generate significant U.S. sales from international medical devices/equipment, may be susceptible
** Neuren NEU.AX, Clarity CU6.AX and Polynovo PNV.AX are among the top gainers on the sub-index, up 20%, 6.7% and 6.3% respectively
** Brokerage expects some impact on country's biggest pharma co CSL CSL.AX given fractionation of its unit's plasma-derived products across Australia, Germany, Switzerland and the U.S.
** Adds, tariffs could impact pharma cos, but lack of details complicates potential impact assessment
** Sub-index down 12.2% YTD, compared to 5% drop in benchmark ASX 200 .AXJO
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.